The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Cellectar Biosciences Inc’s current trading price is -93.02% away from its 52-week high, while its distance from the 52-week low is 9.37%. The stock’s price range for this period has been between $0.22 and $3.51 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.21 million for the day, a number notably higher than the average daily volume of 1.11 million over the last three months.
Cellectar Biosciences Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $3.51 on 05/03/24, while the lowest price for the same period was registered at $0.22 on 12/19/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Cellectar Biosciences Inc (CLRB) has experienced a quarterly rise of 1.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 11.29M and boasts a workforce of 11 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3474, with a change in price of -1.2130. Similarly, Cellectar Biosciences Inc recorded 2,133,872 in trading volume during the last 100 days, posting a change of -83.08%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CLRB stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.
CLRB Stock Stochastic Average
Cellectar Biosciences Inc’s raw stochastic average for the past 50 days is presently 8.97%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 17.61%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 46.59% and 54.57%, respectively.
CLRB Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -18.06% this year. Over the last six months, there has been a stronger performance of -87.93%. The price of CLRB leaped by -22.30% during the last 30 days period. For the last 5-days stocks have slided -21.57%.
